LOREAL_Registration_Document_2017

2017 Consolidated Financial Statements* COMPARED CONSOLIDATED INCOME STATEMENTS

COMPARED CONSOLIDATED INCOME STATEMENTS 4.1.

REMINDER* Reported 2016

2017

Notes

2016 (1)

2015 (1)

2016

2015

€ millions Net sales

3.1 26,023.7 24,916.3 24,290.2 -7,359.2 -7,068.6 -6,994.2 18,664.5 17,847.7 17,295.9 -877.1 -841.2 -787.4 -7,650.6 -7,264.4 -7,132.8 -5,460.5 -5,236.0 -5,042.9 3.1 4,676.3 4,506.1 4,332.9 4 -276.3 -541.3 -188.5

25,837.1 25,257.4 -7,341.7 -7,277.4 18,495.4 17,980.0 -849.8 -794.1 -7,498.7 -7,359.6 -5,607.0 -5,438.6 4,539.9 4,387.7 -543.8 -193.4 3,996.1 4,194.3

Cost of sales Gross profit

Research and development Advertising and promotion

Selling, general and administrative expenses

Operating profit

Other income and expenses

Operational profit

4,400.0 3,964.8 4,144.4

Finance costs on gross debt

-35.5 38.5

-27.4 39.0 11.6 -25.8 346.5

-20.3 59.4 39.1 -43.3 336.9

-32.6 39.1

-23.7 55.6 31.9 -45.7 336.9

Finance income on cash and cash equivalents

Finance costs, net

3.1

6.5

4

Other financial income (expenses)

8.4

-26.0 350.0

-25.8 346.5

Sanofi dividends

Profit before tax and associates

4,727.0 4,297.1 4,477.2 6 -901.3 -1,213.7 -1,229.4

4,323.4 4,517.4 -1,214.6 -1,222.9

Income tax

Share of profit in associates

-0.1

-0.1

4.0

-0.1

4.0

Net profit from continuing operations Net profit from discontinued operations

3,825.6 3,083.4 3,251.8

3,108.7 3,298.5

2.3 -240.1

25.3

46.8

-

-

Net profit

3,585.5 3,108.7 3,298.5

3,108.7 3,298.5

Attributable to: owners of the company s non-controlling interests s

3,581.4 3,105.8 3,297.4

3,105.8 3,297.4

4.1

2.9

1.1

2.9

1.1

Earnings per share attributable to owners of the company (euros) Diluted earnings per share attributable to owners of the company (euros) Earnings per share of continuing operations attributable to owners of the company (euros) Diluted earnings per share of continuing operations attributable to owners of the company (euros) Earnings per share of continuing operations attributable to owners of the company, excluding non-recurring items (euros) Diluted earnings per share of continuing operations attributable to owners of the company, excluding non-recurring items (euros)

6.40 6.36

5.55 5.50

5.92 5.84

5.55 5.50

5.92 5.84

10.4

6.83

5.51

5.83

5.55

5.92

10.4

6.78

5.46

5.75

5.50

5.84

10.4

6.70

6.47

6.17

6.52

6.26

10.4 6.18 The 2016 and 2015 consolidated income statements are presented to reflect the impacts of the application of IFRS 5 relative to discontinued operations, by restating The (1) Body Shop business on a single line “Net profit from discontinued operations” (see note 2.3.). For consistency with the financial information provided outside of the financial statements, we believed it useful to show the Group’s financial performance when The Body * Shop was an integral part of its continuing operations. 6.65 6.41 6.08 6.46

REGISTRATION DOCUMENT / L'ORÉAL 2017

223